Skip to main content
Premium Trial:

Request an Annual Quote

Horizon Plans to Expand in Cambridge

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Horizon Discovery plans to double the size of its office and lab space in Cambridge and it will hire additional staff members, the company said today.

The company is currently seeking to hire up to 10 new staff members for its UK headquarters, which is located at IQ Cambridge, formerly called Cambridge Research Park, Horizon Chairman Darrin Disley said in a statement. The firm expects to have 28 employees at its Cambridge headquarters by the end of this year.

The company also has a staff of six at its facility in Torino, Italy.

The new staff and expanded facilities will support expansion into the companion diagnostics and bio-production markets, Disley added.

Horizon is developing and marketing in vitro discovery and diagnostic tools that can be used to develop and improve cancer drugs, and it is validating and standardizing genetic companion diagnostic tools for cancer. It offers the Genesis gene-targeting platform, and it has a portfolio of genetically defined X-Man human cancer models.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.